2-Azabicyclo[3.3.1]nonanes (morphans) with a (3,4-dichlorophenyl)acetyl group at 2-position and a pyrrolidino moiety at 8-position were designed as conformationally restricted analogs of piperidine-based KOR agonists. The synthesis started with 4-oxopiperidine-2-carboxylic acid comprising 13 reaction steps. At first the ketone 10 was transformed into diester 7 bearing a propionate side chain. Dieckmann condensation of diester 7 to afford bicyclic enolester 14 and subsequent Krapcho deethoxycarbonylation represent the key steps of the synthesis. The enantiomeric pyrrolidines (1S,5R,8R)-5a and (1R,5S,8S)-5a were separated by chiral HPLC. The eutomer (1S,5R,8R)-5a showed high KOR affinity (K-i = 18 nM) and selectivity over MOR, DOR and sigma(2...
Diastereomeric forms of 1-(pyrrolidin-1-ylmethyl)-2-(N-methyl)-4-[(3,4-dichloro)phenyl]-1,2,3,4- tet...
Millions of people in the US currently suffer from chronic pain but available therapeutics do not pr...
The kappa agonist structure–activity relationship around the novel, pyrrolidinyl substituted pyranop...
2-Azabicyclo[3.3.1]nonanes (morphans) with a (3,4-dichlorophenyl)acetyl group at 2-position and a py...
Conformationally restricted bicyclic KOR agonists 10 with an endo-configured amino moiety were synth...
κ opioid receptor (KOR) antagonists are potential pharmacotherapies for the treatment of migraine an...
Cyclic pentapeptide Tyr-c[D-Lys-Phe-Phe-Asp]NH2, based on the structure of endomorphin-2 (EM-2), whi...
We designed and synthesized the 1,3,5-trioxazatriquinane derivatives with <i>m</i>-hydroxyphenyl gro...
1,4-Diazabicyclo[3.3.1]nonanes (aza-morphans) represent conformationally constrained piperazine deri...
In our previous studies, we developed a series of mixed MOR/DOR agonists that are enkephalin-like te...
Four out of the eight possible stereoisomers of 1-methyl-2-(2-methyl-1,3-dioxolan-4-yl)pyrrolidine, ...
Herein, we report that N-alkyl-octahydroisoquinolin-1-one-8-carboxamides are a novel class of readil...
Since the discovery of the powerful analgesic epibatidine in 1974 from the Ecuadorian poison frog Ep...
Our intentions were to design epibatidine analogues containing a distance between the two active nit...
Morphiceptin (Tyr-Pro-Phe-Pro-NH2), a tetrapeptide amide, is a selective ligand of the μ-opioid rece...
Diastereomeric forms of 1-(pyrrolidin-1-ylmethyl)-2-(N-methyl)-4-[(3,4-dichloro)phenyl]-1,2,3,4- tet...
Millions of people in the US currently suffer from chronic pain but available therapeutics do not pr...
The kappa agonist structure–activity relationship around the novel, pyrrolidinyl substituted pyranop...
2-Azabicyclo[3.3.1]nonanes (morphans) with a (3,4-dichlorophenyl)acetyl group at 2-position and a py...
Conformationally restricted bicyclic KOR agonists 10 with an endo-configured amino moiety were synth...
κ opioid receptor (KOR) antagonists are potential pharmacotherapies for the treatment of migraine an...
Cyclic pentapeptide Tyr-c[D-Lys-Phe-Phe-Asp]NH2, based on the structure of endomorphin-2 (EM-2), whi...
We designed and synthesized the 1,3,5-trioxazatriquinane derivatives with <i>m</i>-hydroxyphenyl gro...
1,4-Diazabicyclo[3.3.1]nonanes (aza-morphans) represent conformationally constrained piperazine deri...
In our previous studies, we developed a series of mixed MOR/DOR agonists that are enkephalin-like te...
Four out of the eight possible stereoisomers of 1-methyl-2-(2-methyl-1,3-dioxolan-4-yl)pyrrolidine, ...
Herein, we report that N-alkyl-octahydroisoquinolin-1-one-8-carboxamides are a novel class of readil...
Since the discovery of the powerful analgesic epibatidine in 1974 from the Ecuadorian poison frog Ep...
Our intentions were to design epibatidine analogues containing a distance between the two active nit...
Morphiceptin (Tyr-Pro-Phe-Pro-NH2), a tetrapeptide amide, is a selective ligand of the μ-opioid rece...
Diastereomeric forms of 1-(pyrrolidin-1-ylmethyl)-2-(N-methyl)-4-[(3,4-dichloro)phenyl]-1,2,3,4- tet...
Millions of people in the US currently suffer from chronic pain but available therapeutics do not pr...
The kappa agonist structure–activity relationship around the novel, pyrrolidinyl substituted pyranop...